Changzhou Kony Pharma Co., Ltd

Manufacturing of raw materials (valsartan, valacyclovir hydrochloride, acyclovir, famciclovir, penciclovir, ganciclovir, ciclopirox olamine, rabeprazole sodium, atracurium besylate, perindopril tert-butylamine salt, cinacalcet hydrochloride, eslicarbazepine acetate). Manufacturing of pharmaceutical intermediates (Tetolazole, Adefovir, Nevirapine, Nitrile, Tenofovir, Fluorose, Bismuth Citrate, Potassium Citrate, 7-phenylacetylamino-8-oxo-5-thiabicyclo [4.2.0] oct-2-ene-3-chloromethyl-2-carboxylic acid p-methylbenzyl ester (GCLE for short), 7-phenylacetylamino-8-oxo-5-thiabicyclo [4.2.0] oct-2-ene-3-chloromethyl-2-carboxylic acid diphenyl ester (GCLH for short)); Sales of by-products of the above-mentioned related products (except dangerous goods); Research and development of chemical synthetic APIs and intermediates and technical services; Self-operation and agency of import and export of various commodities and technologies, except for commodities and technologies that are restricted by the state to be operated by companies or prohibited from import and export. (For projects that require approval according to law, business activities can only be carried out after approval by relevant departments) Licensed projects: Dangerous chemicals business; Drug production (For projects that require approval according to law, business activities can only be carried out after approval by relevant departments, and the specific business projects are subject to the approval results)